• 1
    Cush JJ, Lipsky PE. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988; 31: 12308.
  • 2
    Kinne RW, Stuhlmuller B, Burmester GR. Cells of the synovium in rheumatoid arthritis: macrophages. Arthritis Res Ther 2007; 9: 224.
  • 3
    Lundy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheumatoid arthritis: T lymphocytes. Arthritis Res Ther 2007; 9: 202.
  • 4
    Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 120513.
  • 5
    Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008; 26: 65175.
  • 6
    Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L. Gene–environment interaction between the DRB1 shared epitope and smoking in the risk of anti–citrullinated protein antibody– positive rheumatoid arthritis: all alleles are important. Arthritis Rheum 2009; 60: 1597603.
  • 7
    Borthwick NJ, Akbar AN, MacCormac LP, Lowdell M, Craigen JL, Hassan I, et al. Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration. Immunology 1997; 90: 27280.
  • 8
    Ponchel F, Morgan AW, Bingham SJ, Quinn M, Buch M, Verburg RJ, et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood 2002; 100: 45506.
  • 9
    Goronzy JJ, Henel G, Sawai H, Singh K, Lee EB, Pryshchep S, et al. Costimulatory pathways in rheumatoid synovitis and T-cell senescence. Ann N Y Acad Sci 2005; 1062: 18294.
  • 10
    Van Dinther-Janssen AC, Horst E, Koopman G, Newmann W, Scheper RJ, Meijer CJ, et al. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol 1991; 147: 420710.
  • 11
    Rodriguez RM, Pitzalis C, Kingsley GH, Henderson E, Humphries MJ, Panayi GS. T lymphocyte adhesion to fibronectin (FN): a possible mechanism for T cell accumulation in the rheumatoid joint. Clin Exp Immunol 1992; 89: 43945.
  • 12
    Oppenheimer-Marks N, Lipsky PE. Adhesion molecules in rheumatoid arthritis. Springer Semin Immunopathol 1998; 20: 95114.
  • 13
    Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994; 180: 115964.
  • 14
    Vey E, Burger D, Dayer JM. Expression and cleavage of tumor necrosis factor-α and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells. Eur J Immunol 1996; 26: 24049.
  • 15
    McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 1997; 3: 18995.
  • 16
    Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor κB pathways in tumor necrosis factor α production in rheumatoid arthritis. Arthritis Rheum 2002; 46: 3141.
  • 17
    Brennan FM, Smith NM, Owen S, Li C, Amjadi P, Green P, et al. Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function. Arthritis Res Ther 2008; 10: R36.
  • 18
    Buckley CD. Michael Mason prize essay 2003: why do leucocytes accumulate within chronically inflamed joints? Rheumatology (Oxford) 2003; 42: 143344.
  • 19
    Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000; 165: 65908.
  • 20
    Kitani A, Nakashima N, Izumihara T, Inagaki M, Baoui X, Yu S, et al. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol 1998; 161: 49318.
  • 21
    Ueki S, Kihara J, Kato H, Ito W, Takeda M, Kobayashi Y, et al. Soluble vascular cell adhesion molecule-1 induces human eosinophil migration. Allergy 2009; 64: 71824.
  • 22
    Tokuhira M, Hosaka S, Volin MV, Haines GK III, Katschke KJ Jr, Kim S, et al. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum 2000; 43: 112233.
  • 23
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 24
    Beech JT, Brennan FM. Preparation of mononuclear cells from synovial tissue. Methods Mol Med 2007; 135: 10519.
  • 25
    Malik NM, Jin P, Raatz Y, Sumariwalla PF, Kiriakidis S, Shepard M, et al. Regulation of the angiopoietin–Tie ligand–receptor system with a novel splice variant of Tie1 reduces the severity of murine arthritis. Rheumatology (Oxford) 2010; 49: 182839.
  • 26
    Matsuyama T, Kitani A. The role of VCAM-1 molecule in the pathogenesis of rheumatoid synovitis. Hum Cell 1996; 9: 18792.
  • 27
    Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, et al. Up-regulation of stromal cell–derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L–CD40 interaction. Arthritis Rheum 2007; 56: 107686.
  • 28
    McGettrick HM, Smith E, Filer A, Kissane S, Salmon M, Buckley CD, et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 2009; 39: 11325.
  • 29
    Silverman MD, Haas CS, Rad AM, Arbab AS, Koch AE. The role of vascular cell adhesion molecule 1/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 2007; 56: 181726.
  • 30
    Dayer JM, Burger D. Cell-cell interactions and tissue damage in rheumatoid arthritis. Autoimmun Rev 2004; 3 Suppl 1: S146.
  • 31
    Laffon A, Garcia-Vicuna R, Humbria A, Postigo AA, Corbi AL, de Landazuri MO, et al. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 1991; 88: 54652.
  • 32
    Tak PP, Taylor PC, Breedveld FC, Smeets TJ, Daha MR, Kluin PM, et al. Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 1996; 39: 107781.
  • 33
    Bradfield PF, Amft N, Vernon-Wilson E, Exley AE, Parsonage G, Rainger GE, et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell–derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum 2003; 48: 247282.